Device Trial Radar · NCT07569900
A Study to Evaluate the Performance, Usability, and Contrived Result Interpretation of iStatis Gonorrhea Antigen Test
Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
650
Planned (sponsor's estimate)
Start
Nov 26, 2025
Primary completion
Dec 1, 2026
Study completion Jan 1, 2027
Sponsor
- Lead sponsor
- bioLytical LaboratoriesNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Epicentre
- First posted
- May 6, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- No
- Who can join
- Female only, from 16 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the performance, usability, and contrived result interpretation of iStatis Gonorrhea Antigen Test (iStatis Gonorrhea Test) in the intended near-patient or point-of-care setting by trained personnel.
Conditions
- Gonorrhea Infection
Interventions
iStatis Gonorrhea Antigen TestDevice
Vaginal swabs are tested on the iStatis Gonorrhea Antigen Test
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance EvaluationTime frame: 3 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Epicentre Health Research (Johannesburg)
Johannesburg, Gauteng, South Africa · Recruiting
Epicentre Health Research
Durban, KwaZulu-Natal, South Africa · Recruiting
Epicentre Health Research (Cape Town)
Cape Town, Western Cape, South Africa · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.